 |
This milestone reflects the accelerated growth of the company’s international business and provides pharmaceutical enterprises, academic researchers, healthcare providers, and medical technology innovators with trusted, up-to-date, clinically rich, and globally representative real-world data.
Cambridge, Massachusetts, USAJune 24, 2026 /PRNewswire/ — TriNetX, a global leader in federated health data networks, today announced that the TriNetX LIVE™ network has surpassed 300 million patients, serving as a single, federated EHR-native real-world data source aggregating data from over 240 healthcare organizations and more than 13,000 sites worldwide. This milestone enables more organizations dedicated to improving patient care to access richer decision-grade evidence.
Real-world data has historically been fragmented. Drug discovery teams use one data source, trial design teams use another, and post-market safety monitoring uses yet another, with each data handoff being both time-consuming and prone to inconsistencies. A unified, single network covering 300 million patients can support all stages, from hypothesis generation and target identification in early discovery, to patient recruitment, comparative effectiveness research, indication expansion, and post-market pharmacovigilance.
Steve Lethbridge, Senior Vice President of Global Healthcare Partnerships at TriNetX, stated: “300 million is a milestone, not an endpoint. The value that 300 million patients can bring is far more important than the number itself. In the healthcare ecosystem, regardless of who is making decisions that impact patient outcomes, the difference between a well-founded decision and a guess ultimately comes down to whether the data is trusted, up-to-date, rich in clinical detail, and globally representative. That is exactly what our network provides.”
The fastest-growing region of the network is outside the United States. Between April 2025 and April 2026, approximately 52 million new patients were added, with the majority coming from international markets. The network now covers 186 million patients in the U.S., 72 million in Europe, the Middle East, and Africa, 23 million in Latin America, and 21 million in the Asia-Pacific region.
This international breadth is no coincidence; it is a natural outcome of how the network operates. Unlike aggregated data extraction repackaged through intermediaries, the TriNetX LIVE™ network is real-time and bidirectional: data continuously flows from the electronic health record systems of participating healthcare organizations, refreshing near-instantly while fully preserving clinical context.
Request a demo to learn how the TriNetX LIVE™ network can help organizations transform real-world data into decision-grade evidence.